ReviewAmerican journal of neurodegenerative disease2016

Repurposing psychiatric medicines to target activated microglia in anxious mild cognitive impairment and early Parkinson's disease.

Edward C LauterbachPubMed ↗Full text ↗

No numbers read from the abstract.